...
首页> 外文期刊>Journal of Medical Case Reports >Successful thrombolysis of a thrombosed prosthetic mitral valve using a synthetic tissue plasminogen activator: a case report
【24h】

Successful thrombolysis of a thrombosed prosthetic mitral valve using a synthetic tissue plasminogen activator: a case report

机译:使用合成组织纤溶酶原激活剂成功溶栓二尖瓣人工血管溶栓:一例

获取原文

摘要

Introduction Prosthetic valve thrombosis is a rare but life-threatening condition that requires careful evaluation and prompt treatment. While surgical intervention remains the gold standard, thrombolytic therapy is now emerging as a potential substitute. Various thrombolytic treatments including streptokinase, urokinase and recombinant tissue plasminogen activators have been reported with variable success rates. However, the data on the use of tenecteplase (a synthetic tissue plasminogen activator) is limited. Case presentation A 44-year-old Middle Eastern man with a previously implanted prosthetic mitral valve presented with exertional dyspnea and orthopnea. Investigations revealed a thrombosed prosthetic mitral valve. Successful thrombolysis was achieved using tenecteplase which lead to the complete restoration of valve function with no risk to the patient. Conclusion Prosthetic valve thrombosis is a rare but life threatening condition, the diagnosis of which requires a high index of suspicion. Tenecteplase can be used successfully in the management of such cases. It has proved to be useful with no extra risk to the patient.
机译:简介人工瓣膜血栓形成是一种罕见但危及生命的疾病,需要仔细评估和及时治疗。尽管外科手术仍然是金标准,但溶栓治疗正在成为潜在的替代方法。已经报道了各种溶栓治疗方法,包括链激酶,尿激酶和重组组织纤溶酶原激活剂,其成功率各不相同。但是,关于使用替奈普酶(一种合成的组织纤溶酶原激活剂)的数据是有限的。病例介绍一名44岁的中东男子,先前植入了人工二尖瓣,表现为劳累性呼吸困难和正气呼吸。调查显示二尖瓣血栓形成。使用替奈普酶成功完成了溶栓治疗,从而使瓣膜功能完全恢复,对患者没有风险。结论人工瓣膜血栓形成是一种罕见但危及生命的疾病,其诊断需要高度怀疑。替奈普酶可成功用于此类病例的治疗。它被证明是有用的,对患者没有额外的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号